Market News AIOpen the app

Senseonics and Beta Bionics are launching the Eversense 365 system to help manage diabetes better.

ProductRead the original at moomoo.com
Good for SENS

Senseonics' year-long sensor is now part of Beta Bionics' insulin-delivery system, and the launch meets their stated schedule. This expands how its sensor can be used, though no sales or patient-use results are reported.

SENS · Senseonics Holdings, Inc.

AI read · Good for SENS

The AI's read

The combined system puts Senseonics' year-long sensor inside a tool that can deliver insulin automatically. This gives the sensor a place in a broader diabetes treatment offering. The source reports no sales or patient-use results, so the business benefit is not yet proven.

Get alerts for SENS

Follow Senseonics Holdings, Inc. (SENS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SENS
Free on the App Store and Google Play, or on the web.